Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Azelastine/Fluticasone vs Dymista in Seasonal Allergic Rhinitis
NCT02279563Phase 2Unknown
- Sponsor
- Apotex Inc.
- Start
- Dec 2013
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of azelastine, fluticasone propionate nasal spray in seasonal allergic rhinitis (SAR), sponsored by Apotex Inc.. Status: unknown.
02
Drugs
azelastinefluticasone propionate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT02279563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02279563.